Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2018 Sep 24;27(11):1209–1216. doi: 10.1002/pds.4657

Figure 2 – Cumulative incidence curve showing the unadjusted risk of chronic kidney disease during antiretroviral therapy by tenofovir use.

Figure 2 –

CKD, chronic kidney disease